Literature DB >> 8226760

PA28, an activator of the 20 S proteasome, is inactivated by proteolytic modification at its carboxyl terminus.

C P Ma1, P J Willy, C A Slaughter, G N DeMartino.   

Abstract

PA28, a protein activator of the 20 S proteasome, was previously identified in soluble extracts of bovine red blood cells (Ma, C.-P., Slaughter, C. A., and DeMartino, G. N. (1992) J. Biol. Chem. 267, 10515-10523). To determine whether this regulatory protein is as widely distributed as the proteasome, PA28 content and activity were examined in various eukaryotic tissues by immunoblot analysis and by functional assays of tissue extracts. PA28 protein was present in all sources examined. PA28 activity, however, was not detected in many of these sources, including those with the highest level of PA28 protein. To determine the biochemical basis of this result, PA28 was purified from extracts of rat liver, which had high levels of PA28 protein but no PA28 activity. The resulting purified PA28 had no detectable activity but had native and subunit molecular weights indistinguishable from the active PA28 of bovine red blood cells. Using the inactivation of purified PA28 as an assay, a protein that inactivated PA28 without altering its apparent molecular weight on SDS-polyacrylamide gel electrophoresis was identified, purified, and characterized from bovine liver. It had biochemical and catalytic characteristics similar to those of lysosomal carboxypeptidase B. When leupeptin, an inhibitor of lysosomal carboxypeptidase B, was included in the buffers used for the preparation of PA28, PA28 activity was detected in tissues which otherwise failed to demonstrate this activity. A similar result was obtained when extracts were prepared in a manner that minimized disruption of lysosomes. Other carboxypeptidases such as carboxypeptidase Y and pancreatic carboxypeptidase B also inactivated PA28 without altering its apparent molecular weight. Active PA28 binds to the proteasome to form a protease-activator complex that can be isolated after velocity sedimentation centrifugation through glycerol density gradients. Carboxypeptidase-inactivated PA28 failed to form such a complex, suggesting that the carboxyl terminus of PA28 is required for binding to the proteasome. These results indicate the importance of the carboxyl terminus of PA28 for proteasome activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226760

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

Authors:  P Brooks; G Fuertes; R Z Murray; S Bose; E Knecht; M C Rechsteiner; K B Hendil; K Tanaka; J Dyson; J Rivett
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Synthetic peptide-based activators of the proteasome.

Authors:  S Wilk; W E Chen
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 3.  The ubiquitin-proteasome system.

Authors:  Dipankar Nandi; Pankaj Tahiliani; Anujith Kumar; Dilip Chandu
Journal:  J Biosci       Date:  2006-03       Impact factor: 1.826

4.  Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry.

Authors:  David M Smith; Shih-Chung Chang; Soyeon Park; Daniel Finley; Yifan Cheng; Alfred L Goldberg
Journal:  Mol Cell       Date:  2007-09-07       Impact factor: 17.970

Review 5.  Structural and functional properties of proteasome activator PA28.

Authors:  L Kuehn; B Dahlmann
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

6.  The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells.

Authors:  M Jamaluddin; A Casola; R P Garofalo; Y Han; T Elliott; P L Ogra; A R Brasier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  Functional interactions of HslV (ClpQ) with the ATPase HslU (ClpY).

Authors:  Ravishankar Ramachandran; Claudia Hartmann; Hyun Kyu Song; Robert Huber; Matthias Bochtler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 8.  Proteasome activators.

Authors:  Beth M Stadtmueller; Christopher P Hill
Journal:  Mol Cell       Date:  2011-01-07       Impact factor: 17.970

Review 9.  Archaeal proteasomes and sampylation.

Authors:  Julie A Maupin-Furlow
Journal:  Subcell Biochem       Date:  2013

10.  The oncogenic role of REG γ is exerted by activating the Wnt/β-catenin signaling pathway in osteosarcoma.

Authors:  Zhiqiang Yin; Zhibin Peng; Zhichao Wang; Qinggang Meng
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.